Malignant : how bad policy and bad evidence harm people with cancer /
Prasad, Vinayak K., 1982-
Malignant : how bad policy and bad evidence harm people with cancer / How bad policy and bad evidence harm people with cancer Vinayak K. Prasad. - Baltimore : Johns Hopkins University Press, (c)2020. - 1 online resource
Includes bibliographies and index.
The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do?
"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"--
9781421437644
Cancer--Chemotherapy--United States.
Antineoplastic agents--Economic aspects--United States.
Medicine--Research--Economic aspects--United States.
Drug development--Economic aspects--United States.
Medical policy--United States.
Patients--Civil rights--United States.
Medical policy.
Neoplasms--drug therapy
Antineoplastic Agents--economics
Biomedical Research--economics
Drug Development--economics
Health Policy
Patient Rights
Electronic Books.
RC271 / .M355 2020
Malignant : how bad policy and bad evidence harm people with cancer / How bad policy and bad evidence harm people with cancer Vinayak K. Prasad. - Baltimore : Johns Hopkins University Press, (c)2020. - 1 online resource
Includes bibliographies and index.
The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do?
"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"--
9781421437644
Cancer--Chemotherapy--United States.
Antineoplastic agents--Economic aspects--United States.
Medicine--Research--Economic aspects--United States.
Drug development--Economic aspects--United States.
Medical policy--United States.
Patients--Civil rights--United States.
Medical policy.
Neoplasms--drug therapy
Antineoplastic Agents--economics
Biomedical Research--economics
Drug Development--economics
Health Policy
Patient Rights
Electronic Books.
RC271 / .M355 2020